1. Home
  2. Els Van Valckenborgh
  3. Els Van Valckenborgh

Primaire tabs

Zoeken
Limit to
Exporteer 14 resultaten:
Filters: Auteur is Els Van Valckenborgh
2024
Contextual factors influencing the equitable implementation of precision medicine in routine cancer care in Belgium, Schmitt, Tugce, Delnord Marie, Cauët Emilie, Van Valckenborgh Els, and Van den Bulcke Marc , European Journal of Public Health, Apr-03-2026, (2024)
2022
Precision cancer medicine: What has translated into clinical use in Belgium?, Delnord, Marie, Van Valckenborgh Els, Hébrant Aline, Antoniou Aline, Van Hoof Wannes, Waeytens Anouk, and Van den Bulcke Marc , Seminars in Cancer Biology, 2022, Volume 84, p.255 - 262, (2022)
PRECISION: the Belgian molecular profiling program of metastatic cancer for clinical decision and treatment assignment., Thouvenin, J, Van Marcke C, Decoster L, Raicevic Gordana, Punie K, Van den Bulcke Marc, Salgado R, Van Valckenborgh Els, Maes B, Joris S, et al. , ESMO Open, 2022 Aug, Volume 7, Issue 4, (2022)
2021
The Belgian practice and attitudes towards introducing genomics in clinical oncology, Van den Bulcke, Marc, Van Hoof Wannes, Van Valckenborgh Els, Hébrant Aline, Rajcevic Gordana, and Van Assche Kristof , Belgian journal of medical oncology, 2021, Volume 15, Issue 4, p.177 - 185, (2021)
Precision cancer medicine: What has translated into clinical use in Belgium?, Delnord, Marie, Van Valckenborgh Els, Hébrant Aline, Antoniou Aline, Van Hoof Wannes, Waeytens Anouk, and Van den Bulcke Marc , Semin Cancer Biol, 2021 Jun 12, (2021)
2020
NGS for (Hemato-) Oncology in Belgium: Evaluation of Laboratory Performance and Feasibility of a National External Quality Assessment Program, Delcourt, Thomas, Vanneste Kevin, Soumali Mohamed Rida, Coucke Wim, Ghislain V, Hébrant Aline, Van Valckenborgh Els, De Keersmaecker Sigrid C. J., Roosens Nancy, Van de Walle P, et al. , Cancers, Jan-11-2020, Volume 12, Issue 11, (2020)
2019
Algorithms for molecular testing in solid tumours, Hébrant, Aline, Lammens M, Van den Broeck C, D’Haene N., Van den Oord J, Vanderstichele A., Dendooven A, Neven P, Punie K, Floris G, et al. , Belgian Journal of Medical Oncology (BJMO, nov 2019, Volume 13, Issue 7, Number 295, (2019)
Diagnostic testing in myeloid malignancies by next-generation sequencing: recommendations from the commission personalised medicine, Van Valckenborgh, Els, Boone E, Camboni A, Defour JP, Denys B, Devos H, Dewispelaere L, Froyen Guy, Hébrant Aline, Heimann P, et al. , Belgian Journal of Hematology, 2019, Volume 10, Issue 6, Number 249, (2019)
Molecular test algorithms for breast tumours, Hébrant, Aline, Punie K, Duhoux FP, Colpaert C, Floris G, Lambein K, Neven P, Berlière M, Salgado R, Chintinne M, et al. , Belgian Journal of Medical Oncology, 2019, Volume 13, Issue 2, Number 45, (2019)
Standardization of Somatic Variant Classifications in Solid and Haematological Tumours by a Two-Level Approach of Biological and Clinical Classes: An Initiative of the Belgian ComPerMed Expert Panel., Froyen, Guy, Le Mercier Marie, Lierman Els, Vandepoele Karl, Nollet Friedel, Boone Elke, Van der Meulen Joni, Jacobs Koen, Lambin Suzan, Vander Borght Sara, et al. , Cancers (Basel), 2019 Dec 16, Volume 11, Issue 12, (2019)
2018
Opportunities and challenges in oncology and molecular testing: the Belgian strategy, Hébrant, Aline, Van Valckenborgh Els, Salgado Roberto, Froyen Guy, Hulstaert Frank, Roberfroid Dominique, Tejpar Sabine, Jouret-Mourin Anne, Van den Bulcke Marc, and Waeytens Anouk , Belg J Med Oncol , 2018, Volume 12, Issue 2, Number 50, (2018)
Perspectives on the integration of Immuno-Oncology Biomarkers and drugs in a Health Care setting., Vermaelen, K, Waeytens A, Kholmanskikh O, Van den Bulcke Marc, and Van Valckenborgh Els , Semin Cancer Biol, 2018 10, Volume 52, Issue Pt 2, (2018)
Roadbook for the implementation of next-generation sequencing in clinical practice in oncology and hemato-oncology in Belgium., Van Valckenborgh, Els, Hébrant Aline, Antoniou Aline, Van Hoof Wannes, Van Bussel Johan, Pauwels Patrick, Salgado Roberto, van Doren Waltruda, Waeytens Anouk, and Van den Bulcke Marc , Arch Public Health, 2018, Volume 76, (2018)
0
PRECISION: the Belgian molecular profiling program of metastatic cancer for clinical decision and treatment assignment, Thouvenin1,2, J., Van Marcke3 C., Decoster4 L., Raicevic G., Punie K., Vandenbulcke5 M., Salgado R., Van Valckenborgh Els, Maes B., Joris S., et al. , (0)

QR code

QR code for this page URL